3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasm Metastasis
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Myoma
1
Liver Neoplasms
1
Desmoid Tumors
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Interventions
lenvatinib
3
Surgical Procedures, Operative
3
Hepatectomy
3
Cholangiopancreatography, Endoscopic Retrograde
3
Blood Specimen Collection
3
Oxaliplatin
2
Liquid Biopsy
2
Immunohistochemistry
2
Immune Checkpoint Inhibitors
2
Drug Therapy
2
Base Sequence
2
pembrolizumab
1
gemcitabine-oxaliplatin regimen
1
envafolimab
1
Vascular Endothelial Growth Factor A
1
Urination
1
Tegafur
1
Shadowing Technique, Histology
1
S 1 (combination)
1
Radiotherapy
1
Quality of Life
1
Polymerase Chain Reaction
1
Photochemotherapy
1
Patient Reported Outcome Measures
1
Pancreaticoduodenectomy
1
Palliative Care
1
Observation
1
Neoadjuvant Therapy
1
Molecular Diagnostic Techniques
1
Microbiota
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Cholangiocarcinoma
×
Embolization, Therapeutic
×
Clear all
NCT05714124
2024-04-12
LEATUM
IRCCS San Raffaele
Recruiting
580 enrolled